Connect Biopharma Holdings Ltd
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | -88.8% | +229.3% | +1,044.2% | -40.2% | -26.8% | -20.5% | -44.6% | |
| – | -89.0% | +229.4% | +1,010.3% | -43.4% | -21.3% | -20.9% | -47.5% | |
| – | -89.6% | +269.7% | +1,030.4% | -70.5% | +33.7% | -26.0% | -51.0% | |
| – | -89.3% | +240.7% | +1,015.9% | -43.1% | -22.4% | -20.8% | -52.7% | |
| – | -93.2% | +61.6% | +18,162.0% | -96.9% | +51.3% | +199.4% | -84.7% | |
| – | – | +53.4% | -100.1% | – | – | – | – | |
| – | +9.0% | +129.9% | +944.2% | – | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | – | – | +44,007.7% | -10.5% | -98.0% | -14.5% | -15.1% | |
| – | -84.3% | +255.6% | -62.0% | -12.1% | +56.6% | -64.8% | +54.6% | |
| – | -41.2% | +56.8% | +1,918.7% | -13.1% | +61.9% | -66.5% | +60.9% | |
| – | -85.0% | +65.8% | +599.1% | +87.9% | +53.2% | -46.0% | +109.1% | |
| – | -5.4% | +22.3% | +2,104.4% | -6.3% | -81.5% | -84.5% | +474.3% | |
| – | – | – | – | -42.2% | -35.6% | -9.2% | -54.5% | |
| – | – | – | – | – | – | – | – | |
| – | – | -3.4% | -3.1% | +5.3% | +0.0% | +0.3% | +0.8% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.